O2-6-2Progression-free duration of NSCLC patients after cessation of Nivolumab
Mouri, Atsuto, Yamaguti, Ou, Uchida, Takahiro, Shiono, Ayako, Utugi, Harue, Nishihara, Fuyumi, Murayama, Yoshitake, Kobayashi, Kunihiko, Kagamu, HiroshiVolume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx697.050
Date:
October, 2017
File:
PDF, 74 KB
2017